A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Sponsor: Hackensack Meridian Health
Listed as NCT02888366, this observational or N/A phase trial focuses on Breast Cancer and remains completed. Sponsored by Hackensack Meridian Health, it has been updated 11 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Nov 2018 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2018 — Nov 2018 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE2 → NA
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hackensack Meridian Health
- M.D. Anderson Cancer Center
- Menssana Research, Inc.
- St. Michael's Medical Center
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .